AusBiotech has described the US FDA approval of GSK's OJJAARA (momelotinib) as a "huge moment" for Australia's biotechnology community.
AusBiotech lauds Australian-discovered drug after US FDA approval
September 20, 2023 Australian BiotechLatest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Internal promotions for new generation of leaders at Astellas
May 7, 2025 - - Latest News -
New study reveals the far-reaching impact of ovarian cancer
May 7, 2025 - - Latest News -
Just the threat of tariffs has secured a quarter of a trillion in investment
May 7, 2025 - - Latest News -
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech -
OncoSil Medical reports positive results of pancreatic cancer analysis
May 7, 2025 - - Australian Biotech -
Europe warned to adopt positive changes in response to US investment rush
May 7, 2025 - - Latest News -
CLINUVEL recruits 200 patients for Phase 3 vitiligo trial of SCENESSE
May 7, 2025 - - Australian Biotech